Literature DB >> 26151705

Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications.

Kshitij Gupta1, Kirill A Afonin2, Mathias Viard3, Virginia Herrero4, Wojciech Kasprzak5, Ioannis Kagiampakis6, Taejin Kim7, Alexey Y Koyfman8, Anu Puri7, Marissa Stepler7, Alison Sappe7, Vineet N KewalRamani7, Sarina Grinberg4, Charles Linder9, Eliahu Heldman10, Robert Blumenthal7, Bruce A Shapiro11.   

Abstract

In this study we have investigated a new class of cationic lipids--"bolaamphiphiles" or "bolas"--for their ability to efficiently deliver small interfering RNAs (siRNAs) to cancer cells. The bolas of this study consist of a hydrophobic chain with one or more positively charged head groups at each end. Recently, we reported that micelles of the bolas GLH-19 and GLH-20 (derived from vernonia oil) efficiently deliver siRNAs, while having relatively low toxicities in vitro and in vivo. Our previous studies validated that; bolaamphiphiles can be designed to vary the magnitude of siRNA shielding, its delivery, and its subsequent release. To further understand the structural features of bolas critical for siRNAs delivery, new structurally related bolas (GLH-58 and GLH-60) were designed and synthesized from jojoba oil. Both bolas have similar hydrophobic domains and contain either one, in GLH-58, or two, in GLH-60 positively charged head groups at each end of the hydrophobic core. We have computationally predicted and experimentally validated that GLH-58 formed more stable nano sized micelles than GLH-60 and performed significantly better in comparison to GLH-60 for siRNA delivery. GLH-58/siRNA complexes demonstrated better efficiency in silencing the expression of the GFP gene in human breast cancer cells at concentrations of 5μg/mL, well below the toxic dose. Moreover, delivery of multiple different siRNAs targeting the HIV genome demonstrated further inhibition of virus production. Published by Elsevier B.V.

Entities:  

Keywords:  Bolaamphiphiles; Cryo-EM; FRET; Molecular dynamics simulations; RNAi induced gene silencing; siRNA drug delivery

Mesh:

Substances:

Year:  2015        PMID: 26151705      PMCID: PMC4699870          DOI: 10.1016/j.jconrel.2015.06.041

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

1.  From liposomes to supported, planar bilayer structures on hydrophilic and hydrophobic surfaces: an atomic force microscopy study.

Authors:  J Jass; T Tjärnhage; G Puu
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Interfacial and self-assembly properties of bolaamphiphilic compounds derived from a multifunctional oil.

Authors:  Tanya Hutter; Charles Linder; Eliahu Heldman; Sarina Grinberg
Journal:  J Colloid Interface Sci       Date:  2011-08-31       Impact factor: 8.128

Review 3.  Non-viral nucleic acid delivery: key challenges and future directions.

Authors:  Mahmoud Elsabahy; Adil Nazarali; Marianna Foldvari
Journal:  Curr Drug Deliv       Date:  2011-05       Impact factor: 2.565

4.  Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes.

Authors:  Wade W Grabow; Paul Zakrevsky; Kirill A Afonin; Arkadiusz Chworos; Bruce A Shapiro; Luc Jaeger
Journal:  Nano Lett       Date:  2011-01-13       Impact factor: 11.189

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Effect of lipid headgroup charge and pH on the stability and membrane insertion potential of calcium condensed gene complexes.

Authors:  Nabil A Alhakamy; Ibrahim Elandaloussi; Saba Ghazvini; Cory J Berkland; Prajnaparamita Dhar
Journal:  Langmuir       Date:  2015-03-30       Impact factor: 3.882

7.  Synthesis of novel cationic bolaamphiphiles from vernonia oil and their aggregated structures.

Authors:  S Grinberg; V Kolot; C Linder; E Shaubi; V Kas'yanov; R J Deckelbaum; E Heldman
Journal:  Chem Phys Lipids       Date:  2008-02-12       Impact factor: 3.329

8.  Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.

Authors:  Olivier ter Brake; Karen 't Hooft; Ying Poi Liu; Mireille Centlivre; Karin Jasmijn von Eije; Ben Berkhout
Journal:  Mol Ther       Date:  2008-01-15       Impact factor: 11.454

9.  Amphiphilic polyether branched molecules to increase the circulation time of cationic particles.

Authors:  Marie Garinot; Nathalie Mignet; Celine Largeau; Johanne Seguin; Daniel Scherman; Michel Bessodes
Journal:  Bioorg Med Chem       Date:  2007-02-22       Impact factor: 3.641

10.  Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics.

Authors:  Dan Shu; Yi Shu; Farzin Haque; Sherine Abdelmawla; Peixuan Guo
Journal:  Nat Nanotechnol       Date:  2011-09-11       Impact factor: 39.213

View more
  16 in total

1.  Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes.

Authors:  Alexander C Eldredge; Mark E Johnson; Yang Cao; Lin Zhang; Can Zhao; Zhengxia Liu; Qin Yang; Zhibin Guan
Journal:  Biomaterials       Date:  2018-04-16       Impact factor: 12.479

2.  The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities.

Authors:  Kirill A Afonin; Mathias Viard; Philip Tedbury; Eckart Bindewald; Lorena Parlea; Marshall Howington; Melissa Valdman; Alizah Johns-Boehme; Cara Brainerd; Eric O Freed; Bruce A Shapiro
Journal:  Nano Lett       Date:  2016-02-29       Impact factor: 11.189

3.  Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling.

Authors:  Morgan Brittany Johnson; Justin R Halman; Emily Satterwhite; Alexey V Zakharov; My N Bui; Kheiria Benkato; Victoria Goldsworthy; Taejin Kim; Enping Hong; Marina A Dobrovolskaia; Emil F Khisamutdinov; Ian Marriott; Kirill A Afonin
Journal:  Small       Date:  2017-09-18       Impact factor: 13.281

4.  Challenges to optimizing RNA nanostructures for large scale production and controlled therapeutic properties.

Authors:  Morgan Chandler; Martin Panigaj; Lewis A Rolband; Kirill A Afonin
Journal:  Nanomedicine (Lond)       Date:  2020-05-26       Impact factor: 5.307

5.  Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAi.

Authors:  Nadia R Ayat; Zhanhu Sun; Da Sun; Michelle Yin; Ryan C Hall; Amita M Vaidya; Xujie Liu; Andrew L Schilb; Josef H Scheidt; Zheng-Rong Lu
Journal:  Nucleic Acid Ther       Date:  2019-05-28       Impact factor: 5.486

6.  Non-viral Vector Mediated RNA Interference Technology for Central Nerve System Injury.

Authors:  Christian Macks; Jeoung Soo Lee
Journal:  DNA RNA Nanotechnol       Date:  2016-08-25

Review 7.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

Review 8.  Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects.

Authors:  M Brittany Johnson; Morgan Chandler; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-04-20       Impact factor: 17.873

Review 9.  Jojoba Oil: An Updated Comprehensive Review on Chemistry, Pharmaceutical Uses, and Toxicity.

Authors:  Heba A Gad; Autumn Roberts; Samirah H Hamzi; Haidy A Gad; Ilham Touiss; Ahmed E Altyar; Osama A Kensara; Mohamed L Ashour
Journal:  Polymers (Basel)       Date:  2021-05-24       Impact factor: 4.329

Review 10.  Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.

Authors:  Eli P Darnell; Meghan J Mooradian; Erez N Baruch; Melis Yilmaz; Kerry L Reynolds
Journal:  Curr Oncol Rep       Date:  2020-03-21       Impact factor: 5.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.